Care Pathway for Patients With Fabry's Disease (Fabry-PATH)
- Sponsor
- University Hospital, Toulouse
- Study ID
- NCT07485660
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Self-questionnaire — OTHERMedical data of Fabry's disease
Study Details
Fabry's disease is an X-linked disorder that manifests differently in men and women, leading to differences in healthcare pathways. In women, the disease is sometimes diagnosed through family screening despite the presence of symptoms (symptoms appear later than in men, and the phenotypic expression of the disease is sometimes more subtle). Conversely, in men, the presence of symptoms combined with abnormalities in medical examinations facilitates diagnosis. There is limited data on the differences in healthcare pathways between men and women, which could nevertheless impact diagnosis by identifying a profile of at-risk patients, and consequently, their management. The goal of this present study is to describe the differences in care pathways between men and women with Fabry's disease, distinguishing entry via symptoms or family screening through a non-interventional study based on a questionnaire sent to patients and on the collection of medical data at the time of diagnosis.
Key Dates
- Start date
- Apr 30, 2026
- Status verified
- Mar 2026
- Primary completion
- Nov 30, 2026
- Completion
- Nov 30, 2026
Study Design
- Enrollment
- 200 participants (estimated)
Arms
- Arm: Fabry's disease patientsMale and female patients with Fabry's disease diagnosed by the presence of symptoms or following family screening
Primary Outcome Measure
Diagnostic time in care pathways between men and women with Fabry's disease [ Time Frame: 8 months ]
Central Contacts
- Olivier LAIREZ+33561323072
Related Studies
- Fabry Disease Registry & Pregnancy Sub-registryRecruiting · Genzyme, a Sanofi Company · Birmingham, Alabama
- Natural History and Structural Functional Relationships in Fabry Renal Disease Treatment Outcomes(Changes)in Fabry Renal Disease StudyRecruiting · University of Minnesota · Minneapolis, Minnesota
- A Global Prospective Observational Study of Women With Fabry Disease and Their Infants During Pregnancy and BreastfeedingRecruiting · Amicus Therapeutics · Philadelphia, Pennsylvania
- Long-Term Follow-up of Subjects Who Were Treated With ST-920Enrolling By Invitation · Sangamo Therapeutics · Irvine, California